ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "informatics"

  • Abstract Number: 2070 • ACR Convergence 2023

    Augmenting Medical Education: An Evaluation of GPT-4 and ChatGPT in Answering Rheumatology Questions from the Spanish Medical Licensing Examination

    Alfredo Madrid García1, zulema Rosales2, Dalifer Freites2, Inés Pérez Sancristóbal3, Benjamin Fernandez3 and Luis Rodríguez Rodríguez3, 1Fundación Investigación Biomédica Hospital Clínico San Carlos, Madrid, Spain, 2Hospital Clínico San Carlos, Madrid, Spain, 3Hospital Clinico San Carlos, Madrid, Spain

    Background/Purpose: The emergence of Large Language Models (LLM) with remarkable performance such as GPT-4 and ChatGPT, has led to an unprecedented uptake in the population.…
  • Abstract Number: 2323 • ACR Convergence 2023

    An Electronic Health Record-Based Algorithm for Predicting Systemic Lupus Erythematosus Flares: Integrating Clinical Factors and Social Determinants of Health

    Yu Huang1, Lixia Yao2, zhengkang Fan3, Jingchuan Guo1 and Jiang Bian1, 1University of Florida, Gainesville, FL, 2Polygon Health Analytics LLC, Chalfont, PA, 3University of Florida, Gainsville, FL

    Background/Purpose: Systemic lupus erythematosus (SLE) has a relapsing-remitting course, with patients experiencing disease activity flares over time. Flares and prolonged disease activity are associated with…
  • Abstract Number: 2586 • ACR Convergence 2023

    A Novel Blood-Based Assay Differentiates Seropositive and Seronegative Rheumatoid Arthritis from Healthy Individuals and Those with Other Inflammatory Diseases or Osteoarthritis

    Peter C. Taylor1, Jenya Antonova2, Jennifer Geis3, Katharine Dilger3, David Chernoff4, Diana Abdueva3, Nancy Shadick5 and Michael Weinblatt6, 1Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom, 2Compass Strategy and Research, Inc., San Francisco, CA, 3Aqtual Inc., Hayward, CA, 4Chernoff Consulting, Sausalito, CA, 5Brigham and Women's Hospital, Boston, MA, 6Harvard Medical School, Waban, MA

    Background/Purpose: Non-invasive differentiation of seropositive and seronegative rheumatoid arthritis (RA) from other conditions has been limited in the current practice. We aimed to evaluate the…
  • Abstract Number: 0163 • ACR Convergence 2023

    Uncovering Discrepancies: Analysis of Glucocorticoid Exposure Among Patients with Rheumatoid Arthritis in Electronic Health Record Data versus Medicare Claims

    Jing Li1, Julia Kay1, Sharon Abada1, Andriko Palmowski2, Rachael Stovall1, Jinoos Yazdany3 and Gabriela Schmajuk4, 1University of California San Francisco, San Francisco, CA, 2Charité - Universitätsmedizin Berlin, Berlin, Germany, 3University of California, General Department of Medicine, Division of Rheumatology, San Francisco, CA, 4UCSF / SFVA, San Francisco, CA

    Background/Purpose: Understanding glucocorticoid (GC) exposure is critical for observational analyses in rheumatology. However, obtaining an accurate measure of GC exposure, including dosage and duration, has…
  • Abstract Number: 0175 • ACR Convergence 2023

    Predicting Cost-Related Medication Non-Adherence in US Adults with Chronic Arthritis: A Machine Learning Approach

    Ashkan Ara1, Matthew Chenoweth1 and Christopher Scannell2, 1University of California Los Angeles, Los Angeles, CA, 2UCLA / West Los Angeles VA Medical Center, Los Angeles, CA

    Background/Purpose: Cost-related medication non-adherence (CRN) occurs when patients are unable to follow their prescribed medication regimen due to financial constraints, such as high costs or…
  • Abstract Number: 0341 • ACR Convergence 2023

    Patient Perspectives on the Usability of a Rheumatoid Arthritis Patient-reported Outcomes Electronic Health Record-based Dashboard: A Mixed-Methods Study

    Cherish Wilson1, Catherine Nasrallah2, Alicia Hamblin2, Lindsay Jacobsohn2, Cammie Young3, Cammie Young3, Mary Nakamura4, Andrew Gross2, Judith Ashouri2, Brett Dietz2, Mehrdad Matloubian2, Jinoos Yazdany5 and Gabriela Schmajuk1, 1UCSF / SFVA, San Francisco, CA, 2University of California San Francisco, San Francisco, CA, 3University of California San Francisco, Oakland, CA, 4UCSF/SFVAHCS, San Francisco, CA, 5University of California, General Department of Medicine, Division of Rheumatology, San Francisco, CA

    Background/Purpose: Shared decision making, health literacy, and effective communication around patient-reported outcomes (PROs) are vital components to a treat-to-target approach in rheumatoid arthritis (RA) patients.…
  • Abstract Number: 0353 • ACR Convergence 2023

    Validation of Claims-based Algorithms for Newly Diagnosed Juvenile Idiopathic Arthritis Using Machine Learning Methods

    Patricia Hoffman1, Lauren Parlett2, Daniel Beachler2, Daniel Reiff3, Sarah McGuire1, Sonia Pothraj1, Lakshmi Moorthy1, Cynthia Salvant4, Dawn Koffman5, Sanika Rege5, Cecilia Huang5, Matthew Iozzio5, Kevin Schott2, Kevin Haynes6, Amy Davidow7, Stephen Crystal8, Tobias Gerhard5, Brian Strom9, Carlos Rose10 and Daniel Horton4, 1Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, 2Carelon, Wilmington, DE, 3University of Alabama at Birmingham, Birmingham, AL, 4Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, 5Rutgers Center for Pharmacoepidemiology and Treatment Science, New Brunswick, NJ, 6Janssen Pharmaceuticals, Raritan, NJ, 7New York University, New York, NY, 8Rutgers University, New Brunswick, NJ, 9Rutgers, State University of New Jersey, New Brunswick, NJ, 10Thomas Jefferson University, Philadelphia, PA

    Background/Purpose: Administrative claims databases represent important settings for studying large populations with juvenile idiopathic arthritis (JIA), but prior efforts to validate diagnostic algorithms for JIA…
  • Abstract Number: 0807 • ACR Convergence 2023

    Inferring Disease Activity Scores and Low Disease Activity at Registry Visits Based on Structured and Narrative Data from Electronic Health Records

    David Cheng1, Dana Weisenfeld2, Kumar Dahal2, Qing Liu2, Vidul Ayakulangara Panickan3, Mary Jeffway2, Thany Seyok2, Gregory McDermott2, Michael Weinblatt4, Nancy Shadick5, Tianxi Cai6 and Katherine Liao2, 1Massachusetts General Hospital, Boston, MA, 2Brigham and Women's Hospital, Boston, MA, 3Harvard Medical School, Boston, MA, 4Harvard Medical School, Waban, MA, 5Brigham and Women's Hospital, Boston, MA, 6Harvard T.H. Chan School of Public Health, Boston, MA

    Background/Purpose: Real-world data including electronic health records (EHRs) are a promising resource for learning to optimize treatment strategies for rheumatoid arthritis (RA). A major challenge…
  • Abstract Number: 006 • 2023 Pediatric Rheumatology Symposium

    Implementation of Automated Depression Screening in Patients with Lupus in a Tertiary Pediatric Rheumatology Clinic

    Lauren Harper1, Alana Goldstein-Leever1, James Gallup1, Vidya Sivaraman2, Stacy Ardoin1, Kyla Driest1, Evan Mulvhihill3 and Alysha Taxter4, 1Nationwide Children's Hospital, Columbus, OH, 2Nationwide Children's Hospital/ The Ohio State University, Columbus, OH, 3Nemours Children's Hospital, 4Nationwide Children's Hospital, Columbus, OH

    Background/Purpose: Patients with chronic rheumatic conditions, particularly lupus, have higher rates of depression, which significantly impacts their lives and can lead to poor medication compliance…
  • Abstract Number: 018 • 2023 Pediatric Rheumatology Symposium

    Using the Electronic Health Record to Identify Subjects with Rheumatic Disease

    Alysha Taxter1, Matthew Basiaga2, Rajdeep Pooni3, Caitlan Pinotti4, Lisa Buckley5 and CARRA Registry Investigators6, 1Nationwide Children's Hospital, Columbus, OH, 2Mayo Clinic, Rochester, MN, 3Stanford University, Palo Alto, CA, 4Duke, Durham, NC, 5Vanderbilt University Medical Center, Nashville, TN, 6CARRA, Washington, DC

    Background/Purpose: Research teams spend hours manually searching the electronic health records (EHRs) to identify potential candidates eligible for recruitment to the Childhood Arthritis and Rheumatology…
  • Abstract Number: 107 • 2023 Pediatric Rheumatology Symposium

    Validation of Serious Adverse Event Reporting in a Multicenter Registry

    Matthew Basiaga1, Rajdeep Pooni2, Caitlan Pinotti3, Lisa Buckley4, Alysha Taxter5 and CARRA Registry Investigators6, 1Mayo Clinic, Rochester, MN, 2Stanford University, Palo Alto, CA, 3Duke, Durham, NC, 4Vanderbilt University Medical Center, Nashville, TN, 5Nationwide Children's Hospital, Columbus, OH, 6CARRA, Washington, DC

    Background/Purpose: Children with rheumatic disease frequently require management with immune suppressing medications. The benefits of these interventions often outweigh the risks, however serious adverse events…
  • Abstract Number: 115 • 2023 Pediatric Rheumatology Symposium

    Development of an Electronic Clinical Phenotype to Identify Potential Study Subjects with Juvenile Arthritis

    Alysha Taxter1, Marc Natter2, Min-Lee Chang2, Laura Schanberg3, Valarie Morrow4, Eveline Wu5, Tedryl Bumpass4, Alex Fist4, Meg Waite6, Vincent Del Gaizo7, Melanie Kohlheim7 and CARRA Registry Investigators7, 1Nationwide Children's Hospital, Columbus, OH, 2Boston Children's Hospital, Boston, MA, 3Duke University Medical Center, Durham, NC, 4Duke University, Durham, NC, 5UNC Chapel Hill, Chapel Hill, NC, 6Boston Children's Hospital, Boston, MA, 7CARRA, Washington, DC

    Background/Purpose: The LIMIT-JIA trial is the first study of the use of biologic therapy to prevent disease extension in children with newly diagnosed, uncomplicated, oligo-articular…
  • Abstract Number: 1513 • ACR Convergence 2022

    Identification of MRI Lesions Indicative of Spondyloarthritis Diagnosis from the Axial Spondyloarthritis International Society (ASAS) MRImagine Multi-Reader Scoring Dataset Using the Chi-Squared Automatic Interaction Detection Algorithm (CHAID)

    Stephanie Wichuk1, Walter P Maksymowych2, Robert G Lambert1, Abhilash Hareendranathan3 and Jacob Jaremko1, 1University of Alberta, Edmonton, AB, Canada, 2Department of Medicine, University of Alberta, Edmonton, AB, Canada, 3Department of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: Several types of active and structural lesions have been identified on sacroiliac joint MRI of spondyloarthritis (SpA) patients. Various combinations of these lesions may…
  • Abstract Number: 1514 • ACR Convergence 2022

    Self-referral Strategy for Early Diagnosis of Axial Spondyloarthritis- Preliminary Analysis from Finding Axial Spondyloarthritis Study

    Abhijeet Danve, Yale University, New Haven, CT

    Background/Purpose: Lack of timely rheumatology referral for suspected axial spondyloarthritis (axSpA) is a major contributor to delayed diagnosis in patients with chronic back pain (CBP).…
  • Abstract Number: 1739 • ACR Convergence 2022

    Single-Cell Characterization of the TCR Repertoire Across Tissue and Blood in Rheumatoid Arthritis

    Garrett Dunlap1, Aaron Wagner2, Nida Meednu3, Anna Jonsson4, Fan Zhang5, Kevin Wei6, Paul Utz7, William Robinson7, Holden Maecker7, Judith James8, Joel Guthridge8, S. Louis Bridges, Jr.9, Laura Donlin9, Susan Goodman9, Edward DiCarlo9, Vivian Bykerk9, Christopher Ritchlin10, Darren Tabechian11, James Lederer4, Ellen Gravallese12, Mandy McGeachy13, Gary S. Firestein14, Peter Gregersen15, Diane Horowitz16, David Boyle17, Laura Geraldino-Pardilla18, Harris Perlman19, Arthur Mandelin20, Joan Bathon18, Laura Hughes21, V. Michael Holers22, Kevin D Deane23, Larry Moreland22, Andrew Filer24, Costantino Pitzalis25, Lindsy Forbess26, Ami Ben-artzi27, Karen Salomon-Escoto28, Soumya Raychaudhuri4, Michael Brenner12, Accelerating Medicines Partership (AMP) RA/SLE Network29, Andrew McDavid2, Jennifer Anolik3 and Deepak Rao4, 1Harvard University, Boston, MA, 2University of Rochester, Rochester, NY, 3University of Rochester Medical center, Rochester, NY, 4Brigham and Women's Hospital, Boston, MA, 5University of Colorado, Aurora, CO, 6Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 7Stanford University School of Medicine, Palo Alto, CA, 8Oklahoma Medical Research Foundation, Oklahoma City, OK, 9Hospital for Special Surgery, New York, NY, 10Allergy, Immunology and Rheumatology Division, University of Rochester Medical School, Canandaigua, NY, 11URMC, Rochester, NY, 12Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 13University of Pittsburgh, Pittsburgh, PA, 14University of California, San Diego, San Diego, CA, 15The Feinstein Inst for Med Research, Larchmont, NY, 16Northwell Health, Jericho, NY, 17UCSD, La Jolla, CA, 18Columbia University, New York, NY, 19Northwestern University, Chicago, IL, 20Northwestern University Feinberg School of Medicine, Chicago, IL, 21University of Alabama at Birmingham, Birmingham, AL, 22University of Colorado, Denver, CO, 23University of Colorado Denver Anschutz Medical Campus, Denver, CO, 24University of Birmingham, Birmingham, United Kingdom, 25Queen Mary University of London, London, United Kingdom, 26Cedars-Sinai Medical Center, Los Angeles, CA, 27Ami Ben-Artzi, MD Inc., Beverly Hills, CA, 28University of Massachusetts Medical School, Worcester, MA, 29National Institutes of Health, Washington, DC

    Background/Purpose: In rheumatoid arthritis (RA), T cells represent a large proportion of the immune population present in inflamed joint synovium, and subsets of both CD4+…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology